HopeStage
Back to all studies
RecruitingNCT05995769

Psilocybin with motivational therapy for alcohol use: higher or lower dose

About this title

Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder

Read the official source — NCT05995769
Medication studyAges 22–65CanadaAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 65 years.

Listed locations
CalgarySee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 20, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
128
Sponsor
University of Calgary
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
From 22 Years to 65 Years
Official registry ID
NCT05995769
Official title
Show the full official title

Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial

Recruitment & locations

Currently recruiting

Calgary

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Calgary, a university.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: 22 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies